← Open Payments lookup

MAEGEN MCGUFFIN: Open Payments

NPI 1881365864 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$477 in 28 payments from 11 companies in 2025. Trend: 2023 $253 · 2024 $249 · 2025 $477

Food & beverage: $477
CompanyPaymentsAmount
Astellas Pharma US Inc12$193
MAYNE PHARMA COMMERCIAL LLC3$64
Biogen, Inc.2$45
Sumitomo Pharma America, Inc.2$40
Novo Nordisk Inc1$23
Organon LLC3$23
SHIELD THERAPEUTICS INC1$23
Boston Scientific Corporation1$19
Amgen Inc.1$18
Molnlycke Health Care US, LLC1$16

Products named: Veozah, ZURZUVAE, NEXPLANON, ACCRUFER, MYFEMBREE, GEMTESA, Bulkamid, EVENITY.

Industry payments across TX — which companies pay providers there.